BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24929109)

  • 21. Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents.
    Zhou Y; Litvin Y; Piras AP; Pfaff DW; Kreek MJ
    Neuropsychopharmacology; 2011 Sep; 36(10):2062-75. PubMed ID: 21677651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid interactions with alcohol.
    Kreek MJ
    Adv Alcohol Subst Abuse; 1984; 3(4):35-46. PubMed ID: 6391108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous opiates and behavior: 2014.
    Bodnar RJ
    Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases.
    Kreek MJ
    Neurochem Res; 1996 Nov; 21(11):1469-88. PubMed ID: 8947936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of oxytocin in the neuroadaptation to drugs of abuse.
    Sarnyai Z; Kovács GL
    Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.
    Zhou Y; Bendor JT; Yuferov V; Schlussman SD; Ho A; Kreek MJ
    Neuroscience; 2005; 134(4):1391-7. PubMed ID: 16039786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortisol secretion patterns in addiction and addiction risk.
    Lovallo WR
    Int J Psychophysiol; 2006 Mar; 59(3):195-202. PubMed ID: 16434116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
    Wee S; Koob GF
    Psychopharmacology (Berl); 2010 Jun; 210(2):121-35. PubMed ID: 20352414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alcohol and psychostimulants on the vasopressin system: behavioral implications.
    Godino A; Renard GM
    J Neuroendocrinol; 2018 May; ():e12611. PubMed ID: 29802803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The opioid receptors as targets for drug abuse medication.
    Noble F; Lenoir M; Marie N
    Br J Pharmacol; 2015 Aug; 172(16):3964-79. PubMed ID: 25988826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain mechanisms of drug reward and euphoria.
    Wise RA; Bozarth MA
    Psychiatr Med; 1985; 3(4):445-60. PubMed ID: 2893431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic-pituitary-adrenal axis and behavioral dysfunction following early binge-like prenatal alcohol exposure in mice.
    Wieczorek L; Fish EW; O'Leary-Moore SK; Parnell SE; Sulik KK
    Alcohol; 2015 May; 49(3):207-17. PubMed ID: 25709101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
    Bruchas MR; Land BB; Chavkin C
    Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
    Seger D
    Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques.
    Schwandt ML; Lindell SG; Higley JD; Suomi SJ; Heilig M; Barr CS
    Psychoneuroendocrinology; 2011 Oct; 36(9):1303-11. PubMed ID: 21459516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opiates, opioids and addiction.
    Kreek MJ
    Mol Psychiatry; 1996 Jul; 1(3):232-54. PubMed ID: 9118348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats.
    Edwards S; Guerrero M; Ghoneim OM; Roberts E; Koob GF
    Addict Biol; 2012 Jan; 17(1):76-85. PubMed ID: 21309953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain.
    Schroeder JA; Niculescu M; Unterwald EM
    Synapse; 2003 Jan; 47(1):26-32. PubMed ID: 12422370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.